back to top
spot_img

More

collection

Armed Attack at Haiti Hospital Kills at Least 3

At least three folks had been killed, together...

3 life-style adjustments for 2025

Taking care of oneself requires a multi-faceted method:...

Arab diplomats flock to Damascus for conferences with new Syrian chief

Syria’s new chief Ahmed al-Sharaa held talks Monday...

Antibiotics and Antibiotic Resistance – Our World in Data


Antibiotics are one of the essential medical breakthroughs of the twentieth century.1

They have revolutionized healthcare by making it attainable to successfully deal with bacterial infections. Before antibiotics, even minor infections may very well be life-threatening, and medical procedures and surgical procedures had been a lot riskier because of the excessive probability of an infection. As a consequence, antibiotics have saved numerous lives.

But antibiotic resistance challenges their effectiveness. The overuse and misuse of antibiotics have hastened this rising international risk that makes it more durable and extra expensive to deal with infections.

The use of antibiotics is not restricted to human medication: antibiotics are broadly utilized in livestock farming, typically as an inexpensive substitute for higher hygiene requirements.

The world can fight resistance through the use of antibiotics extra fastidiously, growing new medication, regulating antibiotic utilization in livestock, and making certain higher entry to diagnostics and coverings.

On this web page, we discover the historical past, affect, and way forward for antibiotics, and current international knowledge and analysis on antibiotics and antibiotic resistance.

Research & Writing

See all interactive charts on antibiotics ↓

The trendy scientific journey of antibiotics started within the early twentieth century with the microbiologist Paul Ehrlich. He looked for potential medicines that might goal microbes with out harming human cells. In 1910, after testing tons of of compounds, he achieved a breakthrough with salvarsan — the primary efficient therapy for syphilis and the primary artificial antibiotic.2

In another article, we clarify in additional element how completely different antibiotics work.

Another milestone got here in 1928 when Alexander Fleming noticed fungal mould on a contaminated Petri dish that killed micro organism. He had found penicillin.

Unfortunately, scaling up its manufacturing took years.3 In the late Nineteen Thirties and early Nineteen Forties, the U.S. War Production Board coordinated efforts to enhance fermentation, arrange trials, foster collaboration, and elevate patent restrictions — which sped up growth. By 1945, that they had succeeded, making penicillin broadly obtainable.4

Another breakthrough was additionally achieved throughout this time: scientists found the potential of actinomycetes, a gaggle of soil-dwelling micro organism, which ultimately turned the supply of many antibiotics like streptomycin, tetracyclines, and erythromycin.5

The interval between the Nineteen Forties and Sixties is named “the golden age of antibiotics”, as intense analysis into pure and artificial compounds led to the speedy discovery of many new antibiotics.

A timeline titled "The Golden Age of Antibiotics" shows when each antibiotic drug class was first available for medical use, with example antibiotics labeled. Classes are color-coded by their source: actinomycetes, other bacteria, fungi, or synthetic. Milestones include the first antibiotics (arsphenamines in 1910), as well as the discovery of many actinomycetes-derived antibiotics, such as streptomycin, and sulfonamides, penicillins, and tetracyclines. Data: Hutchings, Truman, Wilkinson (2019). Created by Saloni Dattani for Our World in Data.
A timeline of antibiotic drug growth. Data comes from Hutchings et al. (2019).2 Recent antibiotic innovation will be tracked on AntibioticDB. Scripts to recreate this timeline will be discovered on GitHub.

As the timeline reveals, nearly two-thirds of all antibiotic drug courses had been developed and launched through the golden age of antibiotics.

By the Seventies, nonetheless, the antibiotic pipeline slowed down. Pharmaceutical corporations shifted focus to persistent illness therapies, which had been extra worthwhile, particularly as bacterial resistance to antibiotics grew. In addition, efforts to identify new antibiotics by screening organisms for antibiotic exercise typically led to reidentifying the identical compounds already found by others.2

Read extra in our article:

What was the Golden Age of Antibiotics, and how can we spark a new one?

Many antibiotics were developed during the “Golden Age of Antibiotics”. How did it happen, why has antibiotic development slowed down since then, and what can we do to reignite it?

Antibiotics have been efficient towards a variety of bacterial infections, and have additionally helped make childbirth, most cancers therapies, and medical procedures — equivalent to surgical procedures and organ transplants — a lot safer.

Penicillin’s availability meant that streptococcal infections, syphilis, and pneumonia may very well be successfully handled.6 Erythromycin adopted, treating respiratory infections like bronchitis and pneumonia, in addition to pores and skin and ear infections. Tetracyclines had a good broader vary of makes use of, concentrating on proteins frequent in lots of micro organism and a few parasites.7

The most evident instance of their optimistic affect comes from sulfonamides (generally often known as “sulfa medication”), the second class of antibiotics developed. They had been made obtainable within the United States in 1937, earlier than many different new therapies, which makes it attainable to see their affect on demise charges from ailments. This is visualized within the chart beneath.

Sulfa antibiotics might successfully deal with infections equivalent to Streptococcal pneumonia, scarlet fever, and urinary tract infections; they is also used throughout C-sections to scale back the dangers of an infection and sepsis.8

Chart showing the historic impact of sulfa antibiotics on death rates in the United States, 1920–1950. It highlights significant declines in mortality following the introduction of sulfa drugs in 1936–1937.

Sulfa drugs are estimated to have reduced scarlet fever death rates per 100,000 people by 65%.
Sulfa drugs are estimated to have reduced influenza and pneumonia death rates per 100,000 by 24%.
Sulfa drugs are estimated to have reduced maternal mortality per 100,000 live births by 36%.
Sulfa drugs are estimated to have reduced overall mortality per 100,000 people by 3%.

Data comes from National and state-level records, and the mortality estimates were made by researchers Jayachandran et al., 2010. The chart was adapted and republished by Saloni Dattani of Our World in Data.
Seema Jayachandran, Adriana Lleras-Muney, and Kimberly V. Smith (2010).9

Researchers Seema Jayachandran, Adriana Lleras-Muney, and Kimberly V. Smith estimated their affect on demise charges from varied ailments, as proven within the chart above.9

Death charges from infectious ailments had already declined over the earlier a long time within the United States on account of normal enhancements in hygiene, sanitation, and healthcare. But they dropped much more steeply after sulfa antibiotics turned obtainable.

Compared to earlier tendencies, the researchers estimate that sulfa antibiotics resulted in a 36% decline in demise charges from maternal circumstances, a 24% decline from influenza and pneumonia, and a 65% decline in scarlet fever.10

Because of those results, it’s estimated that they led to a 3% decline in demise charges total, translating to an increase within the common life expectancy of round half a yr — a outstanding affect from a single group of antibiotics.9

In many poorer international locations, ailments like pneumonia and diarrhea are the leading causes of child deaths. These diseases are sometimes attributable to micro organism and are treatable with antibiotics however proceed to say lives as a result of many households lack entry to important medicines and healthcare.

One instance of a life-saving program has been the mass drug administration (MDA) of azithromycin, a broad-spectrum antibiotic for kids in poorer areas.11

In a number of giant randomized trials carried out in numerous African international locations — Niger, Burkina Faso, Tanzania, and Malawi — giving azithromycin tablets to youngsters a few times a yr diminished little one mortality charges by round 15%.12 That’s a really giant discount for a single antibiotic.

Azithromycin’s effectiveness comes from its impact on a variety of micro organism, its speedy unfold to a number of organs, and the excessive prevalence of bacterial infections in these areas.13

Beyond saving lives, antibiotics have helped scale back trachoma, a painful bacterial eye an infection that may result in blindness. Large-scale efforts to distribute azithromycin tablets, present clear water, and enhance hygiene considerably diminished the prevalence of trachoma in lots of African areas, as proven within the map beneath.

This image displays two maps of Africa side-by-side, comparing the prevalence of follicular trachoma in children aged 1-9 years across various regions from baseline surveys to the most recent surveys. The left map shows baseline data, while the right map shows more current data. Different colors on the maps indicate the percentage of children affected by trachoma: light purple represents areas where less than 5% of children are affected, progressing through shades of light purple to bright and dark pink, where over 50% of children are affected. The image highlights the decline in trachoma prevalence due to large-scale health interventions like antibiotics, surgeries, and hygiene improvements from 1996 to 2021, based on surveys conducted in 38 countries and involving over 2.6 million people. This chart was created by Saloni Dattani at Our World in Data using data from the study by Kristen Renneker et al. (2022). Global progress toward the elimination of active trachoma:  an analysis of 38 countries.
Data comes from the Global Trachoma Atlas, printed in Kristen Renneker et al. (2022).14

This reveals that focused or high-impact makes use of of antibiotics will be very efficient, though monitoring for antibiotic resistance can be important to keep up excessive efficacy over time.15

Trachoma: how a common cause of blindness can be prevented worldwide

The world has seen a large decline in trachoma, but millions are still at risk. How can we make more progress against it?

The map beneath reveals the utilization of antibiotics to deal with youngsters with respiratory infections. Data comes from large-scale surveys such because the DHS and UN MICS.

This counts all reported respiratory infections, which implies it may possibly additionally embrace antibiotics used to deal with infections attributable to viruses and different pathogens, for which antibiotics are ineffective.

As you possibly can see, in a number of international locations in Eastern Europe and Central and South Asia, it’s frequent for kids to obtain antibiotics for respiratory infections. But it’s a lot much less frequent in components of Africa, the place as few as one in 4 youngsters obtain them in some international locations.

Click to open interactive version

What about antibiotic utilization within the inhabitants as a complete?

Unfortunately, the info for various international locations depends on completely different sources, together with insurance coverage claims, import data, hospital prescriptions, and wholesale knowledge, and might not be consultant of the inhabitants. This can restrict comparability.

The map beneath reveals the info collected by the World Health Organization’s GLASS system, which tracks nationwide antimicrobial use and resistance worldwide. It reveals the typical degree of antibiotic consumption in every nation, as measured by “outlined every day doses” (DDDs) per 1,000 individuals.

For instance, 5 DDDs correspond to the every day quantity of antibiotics usually used to deal with an an infection in 5 individuals.

As you possibly can see, the recorded utilization of antibiotics varies broadly, with excessive charges in components of Asia and a few international locations in Africa and decrease charges in components of Europe. It will be troublesome to make direct comparisons with the earlier map, which confirmed antibiotic utilization amongst youngsters from giant standardized surveys, whereas this knowledge comes from a variety of sources.

The map additionally reveals knowledge for a lot of international locations as lacking, reflecting the restricted nationwide knowledge assortment and reporting on antibiotic utilization.

Click to open interactive version

There are seemingly a number of causes for these variations. One is that charges of infectious ailments range broadly: for instance, tuberculosis rates are round 10 instances increased in sub-Saharan Africa than in Europe.

In addition, a number of international locations, particularly in Europe, use “antibiotic stewardship packages” to observe and restrict the overuse of antibiotics.

When micro organism evolve to evade antibiotics, frequent infections change into a lot more durable to deal with, and life-saving medical procedures and surgical procedures can change into way more harmful. Resistant micro organism also can unfold, resulting in infections which might be more durable and dearer to deal with and infrequently require medicines with larger unintended effects.

The chart right here reveals estimates of the variety of deaths attributable to infectious syndromes, damaged down by whether or not the deaths are attributed to antibiotic resistance — that means they might have been prevented if the an infection wasn’t resistant.

As you possibly can see, deaths attributable to antibiotic resistance are most typical for bloodstream infections and lower-respiratory infections.

A bar chart titled "Global deaths from infectious disease syndromes, broken down by antimicrobial resistance" displays annual data from 2021. The chart categorizes deaths into two groups: those attributed to antimicrobial resistance and those not attributed to it or not assessed for it, represented in contrasting colors (blue for non-attributed and red for attributed).

Listed conditions include:
- Lower respiratory infections: 3.15 million non-attributable, 397,000 attributable.
- Bloodstream infections: 2.95 million non-attributable, 456,000 attributable.
Along with diarrhea, tuberculosis, abdominal infections, kidney and urinary tract infections, skin infections, meningitis, typhoid, paratyphoid, and non-invasive typhoidal salmonella (iNTS), endocarditis, and bone and joint infections.

A note explains that it's estimated at least 456,000 deaths from bloodstream infections could have been prevented if they weren't resistant to antimicrobial drugs. 

Data source: Institute for Health Metrics and Evaluation (IHME) and University of Oxford (2024). The chart was published by Our World in Data.
You can view an interactive model of this chart on-line.

In this associated chart, you possibly can see these estimates damaged down by completely different pathogens:

Global deaths from pathogens attributable to antimicrobial resistance

See the data in our interactive visualization

Globally, it’s estimated that at the least two-thirds of antibiotics are used for livestock.16

Because intensive farming retains animals in cramped and unsanitary circumstances, antibiotics are sometimes used as a less expensive substitute for higher dwelling circumstances and hygiene.

However, overuse can result in the evolution and unfold of antibiotic-resistant micro organism, threatening each animal and human well being. Resistant pathogens can unfold by way of contaminated meat and dairy, making some ailments more durable to deal with.

Antibiotic use varies broadly between animals. Antibiotics are used extra intensively for pigs and sheep than chickens and cattle17, partly on account of their farming circumstances and longer lifespans.

Usage additionally varies world wide, as you possibly can see within the map beneath. The depth of antibiotic use is highest in Asia, Australasia, and the Americas. In distinction, antibiotic use is decrease in Africa on account of decrease entry, and in Europe, partly on account of regulation.

Click to open interactive version

The chart beneath reveals that antibiotic gross sales for livestock have dropped considerably in a number of European international locations.

Several insurance policies have contributed to this, equivalent to necessities for veterinarian prescriptions, taxes on antibiotic gross sales, and prohibiting reductions. In addition, many farms have shifted to utilizing slower-growing animal breeds with out harming farm productiveness.

Click to open interactive version

There are a number of methods to scale back antibiotic overuse in livestock: enhancing sanitary circumstances for animals, utilizing antibiotics solely when essential, and lowering meat consumption.

Cutting meat consumption, even reasonably, might dramatically decrease antibiotic use whereas additionally benefiting the setting and public well being.

Read extra in our article:

Large amounts of antibiotics are used in livestock, but several countries have shown this doesn’t have to be the case

Overuse is a risk for antibiotic resistance, but there are ways to reduce it.

Antibiotic resistance is a rising problem, however there are a number of methods to deal with it.

This contains public well being measures, improved diagnostic know-how and prescription practices, antibiotic stewardship packages, and financial incentives to develop new antibiotics.

Public well being measures to scale back the unfold of bacterial infections

Preventing bacterial infections is one of the most effective ways to combat antibiotic resistance. Vaccination programs, access to clean water and sanitation, and better hygiene practices can significantly reduce infections.

For example, vaccines against Streptococcus pneumoniae and Haemophilus influenzae can protect people from infectious diseases and reduce the need for antibiotics.

Improvements in diagnosis, testing, and usage

It can often take several days to identify infections and to know whether they’re treatable with antibiotics. These delays frequently lead doctors to prescribe broad-spectrum antibiotics, which can be ineffective and fuel resistance.

But testing for bacterial infections and resistance is limited in many countries. Without bacterial testing, it’s difficult to identify whether the disease is caused by a bacterium rather than another pathogen, such as a virus or parasite — for which antibiotics may be ineffective.

Without resistance testing, we can’t quickly identify whether antibiotics are less effective against an infection, help track the spread of antibiotic resistance, and determine whether we’re making progress against it.

With new and faster diagnostic tools, healthcare workers can quickly determine whether an infection is bacterial, what type of bacteria is causing it, and which antibiotics are effective.

In many wealthier countries, antibiotic stewardship programs guide appropriate antibiotic use. These programs help healthcare workers decide when and which antibiotics to prescribe while introducing regulations to reduce misuse.

New antibiotic drug development

As resistance grows, new antibiotics are crucial. However, developing them is difficult, partly due to economic challenges. Antibiotics are typically used for short periods, sold at low prices, and reserved for limited use to slow resistance — making them less profitable for manufacturers.

Governments are addressing this with innovative funding models. For example, the UK is piloting a subscription system where health services pay an annual fee for antibiotic access, encouraging innovation without overuse.

Collaborative initiatives also fund projects to develop essential new drugs. These efforts could revitalize antibiotic discovery and ensure we have effective treatments in the future.

Read more in our article:

What was the Golden Age of Antibiotics, and how can we spark a new one?

Many antibiotics were developed during the “Golden Age of Antibiotics”. How did it happen, why has antibiotic development slowed down since then, and what can we do to reignite it?

In their pure environments, micro organism compete for assets like vitamins and area. Some micro organism produce antibiotics to suppress or kill opponents, giving them a bonus.18 They can goal particular processes in bacterial cells which might be essential for development, replica, and stability, because the diagram beneath reveals.

A diagram illustrating how different types of antibiotics work, featuring a simplified representation of a gram-positive bacterium. The bacterium is depicted with its cell wall and cell membrane labeled, along with internal components like DNA, mRNA, and ribosomes. Surrounding the bacterium are various categories of antibiotics, each with a brief description of their mechanisms and examples: 

- **Cell wall synthesis inhibitors**: Block the formation of the protective cell wall, causing the bacteria to burst. Examples include beta-lactams, glycopeptides, and bacitracin.
- **Cell membrane disruptors**: Damage the cell membrane, leading to leakage of essential contents. It lists enniatins and polymyxins.
- **Folate synthesis inhibitors**: Prevent the production of folate, vital for bacterial growth. Examples given are sulfonamides and diaminopyrimidines.
- **DNA gyrase inhibitors**: Halt the uncoiling of DNA necessary for reproduction and repair, including (fluoro)quinolones.
- **RNA synthesis inhibitors**: Block RNA production needed for protein synthesis, with examples like ansamycins and rifamycins.
- **Protein synthesis inhibitors**: Disrupt protein synthesis machinery essential for growth. Examples include tetracyclines and macrolides.

The diagram notes that gram-positive bacteria possess thick cell walls, making them susceptible to certain antibiotics. At the bottom, there is a source attribution indicating the information is adapted from Sanseverino et al (2018) and Hutchings, Truman and Wilkinson (2019) and licensed under a Creative Commons license.
Adapted from Sanseverino et al. (2018)19 and Hutchings, Truman, and Wilkinson (2019).20

Unfortunately, micro organism can develop resistance to antibiotics. For instance, they will produce enzymes known as “beta-lactamases” that break down beta-lactam antibiotics.6 Bacteria also can produce proteins that pump tetracycline antibiotics out of their cells.21

These mechanisms are likely to evolve inside people (between days to months) however take longer to unfold throughout populations (between weeks to years).

They enable micro organism to adapt to new antibiotics and share resistance mechanisms, together with between completely different species.

Resistance mechanisms can include prices: for instance, producing enzymes like beta-lactamase or sustaining protein pumps can expend vitality or assets, slowing bacterial development.22

However, within the presence of antibiotics, the survival benefit can outweigh the trade-offs, permitting resistant micro organism to dominate over time.

You can learn extra in our article:

How do antibiotics work, and how does antibiotic resistance evolve?

To use antibiotics more effectively, it’s important to know how different antibiotics work and how antibiotic resistance can evolve and spread.

Continue studying on Our World in Data

Causes of Death

To find ways to save lives, it’s essential to know what people are dying from. Explore global data and research on causes of death.

Vaccination

Vaccines are key in making progress against infectious diseases and save millions of lives every year.

Child and Infant Mortality

Child mortality remains one of the world’s largest problems and is a painful reminder of work yet to be done. With global data on where, when, and how child deaths occur, we can accelerate efforts to prevent them.

Cite this work

Our articles and knowledge visualizations depend on work from many alternative individuals and organizations. When citing this matter web page, please additionally cite the underlying knowledge sources. This matter web page will be cited as:

Saloni Dattani, Fiona Spooner, Hannah Ritchie and Max Roser (2024) - “Antibiotics and Antibiotic Resistance” Published on-line at OurWorldinData.org. Retrieved from: 'https://ourworldindata.org/antibiotics' [Online Resource]

BibTeX quotation

@article{owid-antibiotics,
    creator = {Saloni Dattani and Fiona Spooner and Hannah Ritchie and Max Roser},
    title = {Antibiotics and Antibiotic Resistance},
    journal = {Our World in Data},
    yr = {2024},
    notice = {https://ourworldindata.org/antibiotics}
}
Our World in Data logo

Reuse this work freely

All visualizations, knowledge, and code produced by Our World in Data are utterly open entry beneath the Creative Commons BY license. You have the permission to make use of, distribute, and reproduce these in any medium, supplied the supply and authors are credited.

The knowledge produced by third events and made obtainable by Our World in Data is topic to the license phrases from the unique third-party authors. We will all the time point out the unique supply of the info in our documentation, so you need to all the time verify the license of any such third-party knowledge earlier than use and redistribution.

All of our charts can be embedded in any website.

Ella Bennet
Ella Bennet
Ella Bennet brings a fresh perspective to the world of journalism, combining her youthful energy with a keen eye for detail. Her passion for storytelling and commitment to delivering reliable information make her a trusted voice in the industry. Whether she’s unraveling complex issues or highlighting inspiring stories, her writing resonates with readers, drawing them in with clarity and depth.
spot_imgspot_img